- Conditions
- Diabetes Mellitus, Type 2, Acute Coronary Syndrome
- Interventions
- Alogliptin, Placebo
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 5,380 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 292
- States / cities
- Birmingham, Alabama • Dothan, Alabama • Mobile, Alabama + 289 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 78
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Cerebrovascular Disorders, Acute Cerebrovascular Disease
- Interventions
- iNO
- Drug
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 2
- States / cities
- Charlotte, North Carolina
- Conditions
- Ischemic Stroke
- Interventions
- argatroban
- Drug
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2010
- U.S. locations
- 6
- States / cities
- Birmingham, Alabama • Los Angeles, California • New Orleans, Louisiana + 2 more
- Conditions
- Ischemic Stroke, Acute Stroke
- Interventions
- Zoom Reperfusion System
- Device
- Lead sponsor
- Imperative Care, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 328 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 28
- States / cities
- Huntsville, Alabama • Tucson, Arizona • Los Angeles, California + 24 more
- Conditions
- Brain Infarction, Brain Ischemia
- Interventions
- t DC stimulation, tDCStimulation
- Device
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- 19 Years to 90 Years
- Enrollment
- 16 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2015
- U.S. locations
- 1
- States / cities
- Oklahoma City, Oklahoma
- Conditions
- Acute Ischemic Stroke Patients Receiving Reperfusion Therapy
- Interventions
- Low-intensity monitoring strategy, Guideline recommended standard monitoring
- Other
- Lead sponsor
- Craig Anderson
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 4,922 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 20
- States / cities
- Lakewood, Colorado • Littleton, Colorado • Baltimore, Maryland + 15 more
- Conditions
- Hemorrhagic Stroke, Intracerebral, Acute Ischemic Stroke, Traumatic Brain Injury
- Interventions
- Web/mobile/tablet-based digital decision aid + communication (DA+C) tool
- Behavioral
- Lead sponsor
- University of Massachusetts, Worcester
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2026
- U.S. locations
- 3
- States / cities
- Baltimore, Maryland • Worcester, Massachusetts
- Conditions
- Stroke, Cerebrovascular Stroke, Intracerebral Hemorrhage
- Interventions
- Not listed
- Lead sponsor
- Duke University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 6,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Acute Ischemic Stroke, Mesenchymal Stem Cells, Stroke, Acute, Stroke/Brain Attack, Stroke, Ischemic
- Interventions
- Allogeneic human mesenchymal stem cells (Allo-hMSCs)
- Drug
- Lead sponsor
- University of Miami
- Other
- Eligibility
- 18 Years to 80 Years
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Cerebral Stroke, Stroke, Acute, Cerebrovascular Stroke, Ischemic Attack, Transient
- Interventions
- NXY-059
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 3,200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2006
- U.S. locations
- 98
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Fort Smith, Arkansas + 95 more
- Conditions
- Brain Injury, Acute
- Interventions
- Not listed
- Lead sponsor
- Boston Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 720 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2030
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Stroke, Acute, Middle Cerebral Artery Stroke, Posterior Cerebral Artery Stroke
- Interventions
- Human Placenta-Derived Cells PDA001- (cenplacel-L), Placebo
- Biological · Drug
- Lead sponsor
- Celularity Incorporated
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 44 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 1
- States / cities
- Chattanooga, Tennessee
- Conditions
- Dysphagia Following Cerebrovascular Accident
- Interventions
- high intensity dysphagia therapy
- Other
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Dysphagia
- Interventions
- Mann Assessment of Swallowing Ability (MASA) (dysphagia screening tool), Non-standardized clinical swallow evaluation
- Other
- Lead sponsor
- University of Miami
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Cerebrovascular Accident
- Interventions
- NeuroFlo™ Catheter
- Device
- Lead sponsor
- CoAxia
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 26 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 5
- States / cities
- Los Angeles, California • Boston, Massachusetts • Rochester, New York + 2 more
- Conditions
- Cardiovascular Disease, Myocardial Infarction, Stroke, Coronary Revascularization
- Interventions
- Evolocumab, Routine Lipid Management
- Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 6,019 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 81
- States / cities
- Birmingham, Alabama • Fairhope, Alabama • Huntsville, Alabama + 73 more
- Conditions
- Acute Ischemic Stroke
- Interventions
- Enoxaparin sodium
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2003
- U.S. locations
- 1
- States / cities
- Bridgewater, New Jersey
- Conditions
- Acute Ischemic Stroke
- Interventions
- tPA in combination with the Sonolysis Headframe (TUS), tPA in combination with the Sonolysis Headframe (Sham TUS)
- Device
- Lead sponsor
- Cerevast Medical, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 596 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 2
- States / cities
- Memphis, Tennessee • Houston, Texas
- Conditions
- Acute Ischemic Stroke, Transient Ischemic Attack (TIA)
- Interventions
- BMS-986177, Placebo, Clopidogrel, Aspirin
- Drug · Other
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 2,366 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 66
- States / cities
- Birmingham, Alabama • Glendale, California • Long Beach, California + 51 more
- Conditions
- Stroke, Acute, Ischemic Stroke, Acute
- Interventions
- EndovascularThrombectomy, Endovascular thrombectomy with any FDA-approved device
- Procedure · Device
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Acute Coronary Syndrome
- Interventions
- veliflapon (DG-031)
- Drug
- Lead sponsor
- deCODE genetics
- Industry
- Eligibility
- 35 Years and older
- Enrollment
- 3,450 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2006
- U.S. locations
- 11
- States / cities
- Montgomery, Alabama • Jacksonville, Florida • Melrose Park, Illinois + 8 more
- Conditions
- Acute Ischemic Stroke
- Interventions
- endovascular thrombectomy (EVT), Standarad medical care
- Device · Other
- Lead sponsor
- Dr. Michael D Hill
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 530 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 20
- States / cities
- Little Rock, Arkansas • San Francisco, California • Torrance, California + 14 more
- Conditions
- Stroke, Rhabdomyolysis, Jaundice
- Interventions
- Low Dose Lovastatin, Placebo, High Dose Lovastatin
- Drug · Other
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 162 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2015
- U.S. locations
- 7
- States / cities
- Los Angeles, California • Miami, Florida • Atlanta, Georgia + 3 more
- Conditions
- Acute Ischemic Stroke Patients, Large Vessel Occlusion
- Interventions
- Plunger Technique, Static Manual Aspiration Thrombectomy
- Procedure
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee